HomeOncology
Oncology
Artificial mole as an early warning of cancer
Swiss researchers have developed and tested in mice a synthetic gene network that is implanted and serves as an early warning system against the...
One-two drug combo punch an effective treatment for lung cancers
A one-two combo punch using two currently available drugs could be an effective treatment for the majority of lung cancers, a study by scientists...
Common iron compounds may increase colon cancer risk
Two common iron compounds increase the formation of a known biomarker for cancer, according to a study of cancer cells from Chalmers University of...
High amounts of carbs may increase head and neck cancer recurrence risk
Consuming high amounts of carbohydrates and various forms of sugar during the year prior to treatment for head and neck cancer may increase patients'...
Combination Tx targets both tumour cells and tumour blood vessels
Each day, normal human cell tissues express a protein known as p53 that wages war against potential malignancies. However, between 30% and 40% of...
Higher radiation doses not improving survival in prostate cancer patients
A study shows that higher doses of radiation do not improve survival for many patients with prostate cancer, compared with the standard radiation treatment....
Promising family of silver-based anti-cancer drugs discovered
A new family of 'very promising' silver-based anti-cancer drugs has been discovered by researchers in South Africa.
The most promising silver thiocyanate phosphine complex among...
Slow-release hydrogel helps immunotherapy drug kill cancer cells
An immunotherapy drug embedded in a slow-release hydrogel invented at Rice University in collaboration with the University of Texas Health Science Centre at Houston...
High vitamin D levels may link to lower liver cancer risk
High levels of vitamin D may be linked to a lower risk of developing cancer, including liver cancer, concludes a large study of Japanese...
Active lung cancer treatment differences may be raising mortality risk
Differences in the active treatment of lung cancer across England may be cutting short the lives of hundreds of patients with the disease every...
Nuts improve colon cancer recurrence by 42%, mortality by 57%
People with stage III colon cancer who regularly eat nuts are at significantly lower risk of cancer recurrence and mortality than those who don't,...
Weighing risks and benefits in paediatric cancer trials
On average, 1 in 10 children who enrol in paediatric phase I cancer trials are improved after the trial, and 1 in 50 die...
'Obesity paradox' is a significant factor in metastatic melanoma survival
Obese patients with metastatic melanoma who are treated with targeted or immune therapies live significantly longer than those with a normal body mass index...
Kinase inhibitor could be viable in thyroid cancer therapy — trial
A kinase inhibitor called cabozantinib could be a viable therapy option for patients with metastatic, radioactive iodine-resistant thyroid cancer. In a trial initiated and...
Even disclosed placebos help cancer patients with fatigue
Long after cancer treatment ends, many continue to deal with one particular symptom that refuses to go away: fatigue. In a study, researchers at...
EU and WHO reports 'incomplete, unbalanced and uncritical' — international review
Recent reports from the European Union and the World Health Organisation that there is no safe limit for exposure to UV radiation from sunbeds,...
Higher body-fat levels link to invasive breast cancer risk
Among postmenopausal women with normal body mass index (BMI), those with higher body fat levels had an increased risk for invasive breast cancer, according...
Some cancer patients with depression have poorer survival rates
In a study of patients with head and neck cancer, even mild depressive symptoms were associated with poorer overall survival. The findings indicate that...
New cancer diagnostic blood test could 'save countless lives'
A ground-breaking new blood test that can detect eight common types of cancer before they spread will save countless lives, reports The Guardian. Scientists...
Shorter treatment may provide better outcome for some prostate cancer
Treatment with a shorter course of radiation, using higher doses per treatment over fewer days, may be the preferred approach in appropriately selected patients...
Compound may restore immune response in melanoma patients
A novel compound may restore immune response in patients with melanoma, according to a study presented at the ESMO Immuno Oncology Congress 2017. "Checkpoint...
Algerian men rejecting 'mutilated' breast cancer victims
As if losing a breast to cancer was not traumatic enough, Algerian mother-of-three Linda was then spurned by her husband for being “mutilated” and...
Cancer survivors age faster and die earlier
People who have had cancer age faster than those who haven’t lived with the disease, found researchers at the College of Medicine, Mayo Clinic...
Diabetes drug metformin inhibits MDR breast cancer
The drug metformin, typically prescribed to treat type 2 diabetes, keeps breast cancer cells from developing multiple drug resistance (MDR) and can reverse MDR...
Lobectomy best prolongs lives of early stage lung cancer patients
Patients with early stage lung cancer live longer when they receive a lobectomy – the most common type of operation for the disease –...
Drug starts clinical trials in human brain-cancer patients
A drug that spurs cancer cells to self-destruct has been cleared for use in a clinical trial of patients with anaplastic astrocytoma, a rare...
Cancer patients suffering from PTSD
A recent study showed approximately one-fifth of patients with cancer experienced post-traumatic stress disorder (PTSD) several months after diagnosis, and many of these patients...
Osimertinib improves progression-free survival for NSCLC patients
Osimertinib improves progression-free survival compared to standard first line therapy in Asian patients with EGFR-mutated non-small-cell lung cancer (NSCLC), according to the Asian subset...
For cancer patients with HIV, immunotherapy appears safe
Checkpoint inhibitors appear safe to use in patients with both advanced malignancies and HIV according to an early-phase trial.
Medical Xpress reports that study principal...
Biomarker for breast cancer unaffected by breast density
A study has demonstrated that Videssa Breast, a multi-protein biomarker blood test for breast cancer, is unaffected by breast density and can reliably rule...
Most new cancer drugs don't work — 5-year European study
More than half (57%) of cancer drugs authorised by the European Medicines Agency (EMA) between 2009 and 2013 came onto the market without any...
High-tech radiotherapy improves prostate cancer outcomes
A high-tech form of radiotherapy that shapes radiation beams to tumours can dramatically improve outcomes for patients with prostate cancer, long-term clinical trial results...
Exercise improves cognitive ability in breast cancer survivors
In breast cancer survivors, an increase in physical activity more than doubled the women's post-treatment mental processing speed, found a small US pilot study.
It...
Trials raise questions over guidelines against routine PSA screening
After differences in implementation and settings were accounted for, two important prostate cancer screening trials provide compatible evidence that screening reduces prostate cancer mortality....
Cardiovascular Tx link to 50% reduction in lung cancer mortality risk
In most clinical trials for cancer therapy, investigators test treatments in patients with advanced disease. But a recent cardiovascular secondary prevention study has given...
Aspirin cuts colon cancer risk but may make it harder to treat
Daily aspirin use – known to reduce the risk of colon cancer – could also make the disease harder to treat if it does...
Stroke survivors should be checked for cancer development
Some stroke survivors may have 50% higher risk of underlying cancer, according to an observational study presented at the ESMO 2017 Congress in Madrid.
“Post-mortem...
Advance in the treatment of a nal cancer
A European study suggests that rates of lymph node spread from anal cancer are being overestimated, potentially leading to overtreatment of patients with chemo...
Nanolaser finds and kills off metastasised cancer cells
A nanolaser can serve as a super-bright, water-soluble, bio-compatible probe capable of finding metastasised cancer cells in the blood stream and then killing these cells,...
Worse outcomes when receiving alternative therapy for curable cancers
Patients who choose to receive alternative therapy as the treatment for curable cancers, instead of conventional cancer treatment, have a higher risk of death,...